TY - JOUR
T1 - Autophagy in the cancer-immunity dialogue
AU - Yamazaki, Takahiro
AU - Bravo-San Pedro, José Manuel
AU - Galluzzi, Lorenzo
AU - Kroemer, Guido
AU - Pietrocola, Federico
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Autophagy is quintessential for the maintenance of cellular homeostasis in all eukaryotic cells, explaining why both normal and malignant cells benefit from proficient autophagic responses. Moreover, autophagy is intimately involved in the immunological control of malignant transformation, tumor progression and response to therapy. However, the net effect of autophagy activation or inhibition on the natural growth or therapeutic response of tumors evolving in immunocompetent hosts exhibits a considerable degree of context dependency. Here, we discuss the complex cross-talk between autophagy and immuno-oncology as delineated by genetic and pharmacological approaches in mouse models of cancer.
AB - Autophagy is quintessential for the maintenance of cellular homeostasis in all eukaryotic cells, explaining why both normal and malignant cells benefit from proficient autophagic responses. Moreover, autophagy is intimately involved in the immunological control of malignant transformation, tumor progression and response to therapy. However, the net effect of autophagy activation or inhibition on the natural growth or therapeutic response of tumors evolving in immunocompetent hosts exhibits a considerable degree of context dependency. Here, we discuss the complex cross-talk between autophagy and immuno-oncology as delineated by genetic and pharmacological approaches in mouse models of cancer.
KW - ATG5
KW - Antigen presentation
KW - Beclin 1
KW - CGAS/STING signaling
KW - Cytotoxic T lymphocytes
KW - Dendritic cells
KW - Mitophagy
KW - T cells
UR - http://www.scopus.com/inward/record.url?scp=85097865234&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2020.12.003
DO - 10.1016/j.addr.2020.12.003
M3 - Review article
C2 - 33301821
AN - SCOPUS:85097865234
SN - 0169-409X
VL - 169
SP - 40
EP - 50
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
ER -